Skip to main content

Abstract

Leprosy is an infectious and contagious chronic disease, affecting mainly the skin and the peripheral nerves. It may cause disability due to the peripheral neurological damage, as well as from the ocular disease. Although less frequent, the latter may be severe and irreversible.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Agrawal A, Pandit L, Dalal M et al (2005) Neurological manifestations of Hansen’s disease and their management. Clin Neurol Neurosurg 107:445–454

    Article  PubMed  Google Scholar 

  2. Boratto LM, Oréfice F, Werner LP et al (1998) Dacryocystographic examination does not identify early seventh nerve failure in leprosy patients. Indian J Lepr 70:287–289

    CAS  PubMed  Google Scholar 

  3. Ministério da Saúde do Brasil (2002) Secretaria de Políticas de Saúde – Departamento de Atenção Básica. Guia para o Controle da Hanseníase. Brasília, 89 p

    Google Scholar 

  4. Ministério da Saúde do Brasil (2003) Secretaria de Políticas de Saúde – Departamento de Atenção Básica. Manual de Condutas para Complicações Oculares. Brasília, 59 p

    Google Scholar 

  5. Britton WJ (1998) The management of leprosy reversal reactions. Lepr Rev 69:225–234

    CAS  PubMed  Google Scholar 

  6. Britton WJ, Lockwood DN (2004) Leprosy. Lancet 363:1209–1219

    Article  PubMed  Google Scholar 

  7. Campos WB, Oréfice F, Rodrigues CA et al (1996) Mycobacterium leprae scleritis in a patient after many years of dapsone therapy. Rev Bras Oftalmol 55:167–174

    Google Scholar 

  8. Campos WB, Oréfice F, Sucena MA et al (1998) Conjunctival biopsy in patients with leprosy. Indian J Lepr 70:291–294

    CAS  PubMed  Google Scholar 

  9. Campos WR, Oréfice F, Sucena MA et al (1998) Bilateral iridocyclitis caused by Mycobacterium leprae diagnosed through paracentesis. Indian J Lepr 70:27–31

    CAS  PubMed  Google Scholar 

  10. Campos WB, Rodrigues CA, Oréfice F et al (1995) M. leprae eradication by multidrug therapy and superior tarsal conjunctival scrape. Rev Bras Oftalmol 54:267–274

    Google Scholar 

  11. Campos WR, Rodrigues CA, Oréfice F et al (1998) Identification of M.leprae in conjunctiva of leprosy patients using the superior tarsal conjunctiva scrape technique. Indian J Lepr 70:397–403

    CAS  PubMed  Google Scholar 

  12. Campos WR, Rodrigues CAF, Oréfice F (2005) Hanseníanse. In: Oréfice F (ed) Uveíte clínica e cirúrgica. Cultura Médica, Rio de Janeiro, pp 419–448

    Google Scholar 

  13. Daniel E, Koshy S (2002) Intraocular lens implantation in leprosy. Int J Lepr Other Mycobact Dis 70:9–15

    PubMed  Google Scholar 

  14. Daniel E, Koshy S, Rao GS et al (2002) Ocular complications in newly diagnosed borderline lepromatous and lepromatous leprosy patients: baseline profile of the Indian cohort. Br J Ophthalmol 86:1336–1340

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Daniel E, Sundar Rao PS (2007) Evolution of vision reducing cataract in skin smear positive lepromatous patients: does it have an inflammatory basis? Br J Ophthalmol 91:1011–1013

    Article  PubMed Central  PubMed  Google Scholar 

  16. Frota E, Oréfice F (1989) Intraocular lens in patients bearing Hansen’s disease. Rev Bras Oftalmol 48:205–207

    Google Scholar 

  17. Hogeweg M, Keunen JE (2005) Prevention of blindness in leprosy and the role of the Vision 2020 Programme. Eye 19:1099–1105

    Article  CAS  PubMed  Google Scholar 

  18. Katoch VM (2002) Advances in the diagnosis and treatment of leprosy. Expert Rev Mol Med 4:1–14

    Article  PubMed  Google Scholar 

  19. Mendes AG, Oréfice F, Campos WB et al (1996) Comparison between the Semmes-Weinstein and the Cochet & Bonnet esthesiometers in the evaluation of corneal sensitivity. Rev Bras Oftalmol 55:41–51

    Google Scholar 

  20. Monteiro LG, Campos WR, Oréfice F et al (1998) Study of ocular changes in leprosy patients. Indian J Lepr 70:197–202

    CAS  PubMed  Google Scholar 

  21. Murthy PK (2004) Clinical manifestations, diagnosis and classification of leprosy. J Indian Med Assoc 102:678–679

    PubMed  Google Scholar 

  22. Mvogo CE, Bella-Hiag AL, Ellong A et al (2001) Ocular complications of leprosy in Cameroon. Acta Ophthalmol Scand 79:31–33

    Article  CAS  PubMed  Google Scholar 

  23. Oréfice F, Boratto LM (1998) Clinical ocular study in leprosy patients at a sanitary dermatological hospital in Brazil. Indian J Lepr 70:189–195

    PubMed  Google Scholar 

  24. Oréfice F, Miranda D, Boratto LM (1998) Presence of M. leprae in the conjunctiva, vitreous body and retina of a patient having lepromatous leprosy. Indian J Lepr 70:97–102

    PubMed  Google Scholar 

  25. Samanta SK, Das D (2007) Recent advances in ocular leprosy. Indian J Lepr 79:135–150

    CAS  PubMed  Google Scholar 

  26. Scollard DM, Adams LB, Gillis TP et al (2006) The continuing challenges of leprosy. Clin Microbiol Rev 19:338–381

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Thompson KJ, Allardice GM, Babu GR et al (2006) Patterns of ocular morbidity and blindness in leprosy–a three centre study in Eastern India. Lepr Rev 77:130–140

    PubMed  Google Scholar 

  28. Waddell KM, Saunderson PR (1995) Is leprosy blindness avoidable? The effect of disease type, duration, and treatment on eye damage from leprosy in Uganda. Br J Ophthalmol 79:250–256

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Walker SL, Waters MF, Lockwood DN (2007) The role of thalidomide in the management of erythema nodosum leprosum. Lepr Rev 78:197–215

    PubMed  Google Scholar 

  30. World Health Organization (1998) Expert committee on leprosy, 7th Report: 1–43

    Google Scholar 

  31. World Health Organization (2007) Weekly epidemiological record 82:225–232. Available at http://www.who.int/wer

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fernando Oréfice MD, PhD .

Editor information

Editors and Affiliations

1 Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Case Report 57

Leprosy (PPT 4098 kb)

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Oréfice, F., Campos, W.R., Cordeiro, C.A. (2016). Leprosy. In: Zierhut, M., Pavesio, C., Ohno, S., Orefice, F., Rao, N. (eds) Intraocular Inflammation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-75387-2_102

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-75387-2_102

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-75385-8

  • Online ISBN: 978-3-540-75387-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics